RT Journal Article
SR Electronic
T1 Cognitive predictors of vaccine hesitancy and COVID-19 mitigation behaviors in a population representative sample
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.02.22268629
DO 10.1101/2022.01.02.22268629
A1 Hudson, Anna
A1 Hall, Peter A.
A1 Hitchman, Sara C.
A1 Meng, Gang
A1 Fong, Geoffrey T.
YR 2022
UL http://medrxiv.org/content/early/2022/01/03/2022.01.02.22268629.abstract
AB With the continued threat of COVID-19, predictors of vaccination hesitancy and mitigation behaviors are critical to identify. Prior studies have found that cognitive factors are associated with some COVID-19 mitigation behaviors, but few studies employ representative samples and to our knowledge no prior studies have examined cognitive predictors of vaccine hesitancy. The purpose of the present study, conducted among a large national sample of Canadian adults, was to examine associations between cognitive variables (executive function, delay discounting, and temporal orientation) and COVID-19 mitigation behaviors (vaccination, mask wearing, social distancing, and hand hygiene). Findings revealed that individuals with few executive function deficits, limited delay discounting and who adopted a generally future-orientation mindset were more likely to be double-vaccinated and to report performing COVID-19 mitigation behaviors with high consistency. The most reliable findings were for delay discounting and future orientation, with executive function deficits predicting mask wearing and hand hygiene behaviors but not distancing and vaccination. These findings identify candidate mediators and moderators for health communication messages targeting COVID-19 mitigation behaviors and vaccine hesitancy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by an operating grant to P. Hall, G. Fong and S. Hitchman by the Canadian Institutes for Health Research (CIHR), Institute for Population and Public Health (GA3-177733).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was reviewed by and received approval from the University of Waterloo Office of Research Ethics. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon reasonable request to either of the corresponding authors.